These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19686790)

  • 1. The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.
    Zhou Q; Carlsson A; Botros M; Fransson R; Sandström A; Gordh T; Hallberg M; Nyberg F
    Peptides; 2009 Dec; 30(12):2418-22. PubMed ID: 19686790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.
    Zhou Q; Kindlundh AM; Hallberg M; Nyberg F
    Peptides; 2004 Nov; 25(11):1951-7. PubMed ID: 15501527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P in the cerebrospinal fluid-contacting nucleus contributes to morphine physical dependence in rats.
    Lu XF; Li YY; Wang CG; Wei JQ; Ye Y; Zhang LC; Cao JL
    Neurosci Lett; 2011 Jan; 488(2):188-92. PubMed ID: 21093542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.
    Carlsson A; Ohsawa M; Hallberg M; Nyberg F; Kamei J
    Eur J Pharmacol; 2010 Jan; 626(2-3):250-5. PubMed ID: 19836387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
    Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
    Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differences in activity between substance P and substance P-heptapeptide as studied on the phenomenon of "gut dependence" in rats (author's transl)].
    Nieber K; Oehme P
    Pharmazie; 1982 May; 37(5):368-9. PubMed ID: 6180443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.
    Zhou Q; Nyberg F
    Neurosci Lett; 2002 Mar; 320(3):117-20. PubMed ID: 11852176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors.
    Woldbye DP; Klemp K; Madsen TM
    J Pharmacol Exp Ther; 1998 Feb; 284(2):633-6. PubMed ID: 9454808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture attenuates morphine withdrawal signs and c-Fos expression in the central nucleus of the amygdala in freely moving rats.
    Liu S; Zhou W; Liu H; Yang G; Zhao W
    Brain Res; 2005 May; 1044(2):155-63. PubMed ID: 15885214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
    Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
    Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
    Shahidi S; Hasanein P
    Brain Res Bull; 2011 Aug; 86(1-2):118-22. PubMed ID: 21763761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal.
    Zhou Q; Frändberg PA; Kindlundh AM; Le Grevès P; Nyberg F
    Peptides; 2003 Jan; 24(1):147-53. PubMed ID: 12576096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.